Back to search
FDAFDA · Food and drugs·Recall number Z-1681-2018

IMMULITE ¿ 2000/IMMULITE ¿ 2000 XPi Gastrin

Published May 16, 2018 · Recall initiated: January 2, 2018

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA, Folic Acid, Gastrin, OM-MA (CA125), Thyroglobulin, and Vitamin B12, and these assays are susceptible to interference from biotin.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Nationwide and Canada, Mexico, and Thailand
Lot
Gastrin, Gastrin (IMMULITE/IMMULITE 1000, LKGA1), (IMMULITE 2000/IMMULITE 2000 XPi, LKGA2) Lot codes: 251 252 253 254 255
Risk classification
Class II
Area (FDA)
device
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card